KATELYNN SAK: Open Payments
NPI 1114539897 · NOKOMIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,201 in 39 payments from 12 companies in 2025. Trend: 2023 $275 · 2024 $295 · 2025 $1,201
Food & beverage: $1,201
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $207 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $181 |
| E.R. Squibb & Sons, L.L.C. | 4 | $171 |
| Boston Scientific Corporation | 1 | $150 |
| Novartis Pharmaceuticals Corporation | 6 | $131 |
| Alnylam Pharmaceuticals Inc. | 3 | $86 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Amgen Inc. | 4 | $67 |
| Esperion Therapeutics, Inc. | 3 | $65 |
| GlaxoSmithKline, LLC. | 2 | $31 |
Products named: LifeVest, VYNDAQEL, WATCHMAN FLX, CAMZYOS, LEQVIO, ONPATTRO, JARDIANCE, REPATHA.
Industry payments across FL — which companies pay providers there.
